Cytokinetics to Announce First Quarter Results on May 8, 2024
Cytokinetics Inc CYTK
News
-
Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress
Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session
Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Cytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Cytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 73rd Annual Scientific Session
Cytokinetics to Participate in March Investor Conferences
Super Micro Computer and Deckers Outdoor Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
This biotech ETF sees 'breakout' while U.S. small-cap technology stocks lag
Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day
Cytokinetics, The Mended Hearts, Inc. and WomenHeart Announce Launch of New Initiative to Increase Engagement in Cardiovascular Clinical Trials
Cytokinetics Reports Fourth Quarter 2023 Financial Results
Cytokinetics to Announce Fourth Quarter Results on February 27, 2024
Cytokinetics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
Cytokinetics Announces Recipients of Its Sixth Annual Communications Grant Program
Cytokinetics Shares Slide as Novartis Reportedly Shies Away From Deal
Cytokinetics Shares Jump 16% After WSJ Report of Novartis Deal
Novartis, Cytokinetics near merger: report